Cargando…

Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma

Background. Osteopontin (OPN) is a multifunctional cytokine involved in cell survival, migration, and adhesion. However, its role in chemosensitivity in locally advanced oral squamous cell carcinoma (OSCC) in humans has not yet been investigated. Methods. We enrolled 121 patients with locally advanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Sheng-Dean, Chen, Yi-Ju, Liu, Chien-Ting, Rau, Kun-Ming, Chen, Yi-Ching, Tsai, Hsin-Ting, Chen, Chang-Han, Chiu, Tai-Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605257/ https://www.ncbi.nlm.nih.gov/pubmed/26491674 http://dx.doi.org/10.1155/2015/508587

Ejemplares similares

High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area
por: Chiu, Tai-Jan, et al.
Publicado: (2011)

Osteopontin Expression Is Associated with the Poor Prognosis in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
por: Chiu, Tai-Jan, et al.
Publicado: (2018)

Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2018)

Overexpression of Fli-1 in astrocytoma is associated with poor prognosis
por: Tsai, Hung-Pei, et al.
Publicado: (2017)

Prognosis of Midkine and AT1R expression in resectable head and neck squamous cell carcinoma
por: Chiu, Tai-Jan, et al.
Publicado: (2023)

Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior
por: Chien, Chih-Yen, et al.
Publicado: (2014)

Ribophorin II Overexpression Is Associated with Poor Response to Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in P16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Chen, Wei-Shan, et al.
Publicado: (2021)

Metformin disrupts malignant behavior of oral squamous cell carcinoma via a novel signaling involving Late SV40 factor/Aurora-A
por: Chen, Chang-Han, et al.
Publicado: (2017)

High expression of GSKIP is associated with poor prognosis in meningioma
por: Cheng, Yu-Wen, et al.
Publicado: (2022)

Comparative Study of Esophageal Stent and Feeding Gastrostomy/Jejunostomy for Tracheoesophageal Fistula Caused by Esophageal Squamous Cell Carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2012)

Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis
por: Hwang, Chung-Feng, et al.
Publicado: (2013)

CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma
por: Pai, Shin, et al.
Publicado: (2019)

SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma
por: Chuang, Hao-Wen, et al.
Publicado: (2021)

Intra-Arterial Chemotherapy with Doxorubicin and Cisplatin Is Effective for Advanced Hepatocellular Cell Carcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2014)

Osteopontin and integrin are involved in cholesterol gallstone formation
por: Yang, Lin, et al.
Publicado: (2012)

High Expression of GOLPH3 in Esophageal Squamous Cell Carcinoma Correlates with Poor Prognosis
por: Wang, Jian-Hua, et al.
Publicado: (2012)

High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma
por: Lin, Yueh-Min, et al.
Publicado: (2015)

HOXC8 mediates osteopontin expression in gastric cancer cells
por: Tsai, Chung-Yu, et al.
Publicado: (2023)

Direct Binding of Cisplatin to p22phox, an Endoplasmic Reticulum (ER) Membrane Protein, Contributes to Cisplatin Resistance in Oral Squamous Cell Carcinoma (OSCC) Cells
por: Hung, Chih-Chang, et al.
Publicado: (2020)

Expression of Osteopontin in oesophageal squamous cell carcinoma
por: Kita, Y, et al.
Publicado: (2006)

C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer
por: Lin, Mei-Chun, et al.
Publicado: (2018)

Clinical Significance of Down-Regulated CD70 and CD27 Expression in Poor Prognosis of Esophageal Squamous Cell Carcinoma
por: Shan, Ting-ting, et al.
Publicado: (2020)

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
por: Ma, Yu-Shui, et al.
Publicado: (2021)

Osteopontin as a biomarker for osteosarcoma therapy and prognosis
por: Han, Xingwen, et al.
Publicado: (2019)

NM23-H1 expression of head and neck squamous cell carcinoma in association with the response to cisplatin treatment
por: Wang, Yi-Fen, et al.
Publicado: (2014)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

7‐Epitaxol induces apoptosis in cisplatin‐resistant head and neck squamous cell carcinoma via suppression of AKT and MAPK signalling
por: Yang, Hui‐Ju, et al.
Publicado: (2022)

High Serum Elafin Prediction of Poor Prognosis of Locoregional Esophageal Squamous Cell Carcinoma
por: Wu, I-Chen, et al.
Publicado: (2021)

Increased interleukin-6 expression is associated with poor prognosis and acquired cisplatin resistance in head and neck squamous cell carcinoma
por: GAO, JIAN, et al.
Publicado: (2016)

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
por: Hou, Hsin-An, et al.
Publicado: (2016)

High expression of dedicator of cytokinesis 1 (DOCK1) confers poor prognosis in acute myeloid leukemia
por: Lee, Sze-Hwei, et al.
Publicado: (2017)

EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma
por: Bi, Yanghui, et al.
Publicado: (2019)

Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients
por: Chen, Tzu-Ju, et al.
Publicado: (2022)

DEK overexpression is predictive of poor prognosis in esophageal squamous cell carcinoma
por: Yi, Huochun, et al.
Publicado: (2019)

The Indication of Poor Prognosis by High Expression of ENO1 in Squamous Cell Carcinoma of the Lung
por: Huang, Wan-Ying, et al.
Publicado: (2021)

PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway
por: Pai, Shin, et al.
Publicado: (2021)

Substance Use (Alcohol, Areca Nut and Cigarette) Is Associated with Poor Prognosis of Esophageal Squamous Cell Carcinoma
por: Wu, I-Chen, et al.
Publicado: (2013)

Cisplatin-Induced Giant Cells Formation Is Involved in Chemoresistance of Melanoma Cells
por: Weng, Chien-Hui, et al.
Publicado: (2020)

Overexpression of MMP13 Is Associated with Clinical Outcomes and Poor Prognosis in Oral Squamous Cell Carcinoma
por: Vincent-Chong, Vui King, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d3h069scvhlli4ie781j6sea54